LIFE Reverse Equity Fund IV

Thawer & Co., VII LLP.

Healthcare Fund (NA Ventures)

Enhancing Human Lives through Conceptualization, Innovation & Implementation.
Fund Inception: 2012-03 (March 2012).

Fund Projected Exit: 2013-06 (June 2013).

We are now accepting investment opportunities.

This document contains private and confidential information and is not to be distributed to the general public.

LIFE Fund Team Profile

General Partner: Thawer & Co., VII LLP. Fund Manager: Thawer & Co., VII LLP.

Auditor: Dugan, Colthart & Zoch, P.A.

Legal Counsel: Greenberg Traurig, LLP. Financial Institution: Charles Schwab & Co., Inc.

Monetizing Partner: TBD.

Venture Strategist Firm: TBD. Investment Bank: Sonenshine Partners (Exit).

This document contains private and confidential information and is not to be distributed to the general public.

LIFE Reverse Equity Fund IV

Industry: Healthcare, Medical, Pharmaceuticals, Biotechnology, etc. Investment Stage: All Except Seed / 12Mths to Rev.

Min Equity Contribution Limit: $250k Stock or 5% Equity.

Investment To Revenue Range: $1M-$5M. Investment Demographics: USA.

Exit: Predefined Acquisition via Secondary.

Fund Subscription: $25M. Fund Inception: 2012-03 (March 2012). Fund Exit: 2013-06 (June 2013).

This document contains private and confidential information and is not to be distributed to the general public.

LIFE Reverse Equity Fund IV Objective

Fully Capitalize Portfolio Ventures. Long term Assets & Stock Appreciation.

High Growth Potential & Liquidity.

Projected 4X Exit at $100M+. Expertise, Experience & Reputation of the Fund.

12-18 Months Exit Strategies upon Full Subscription.

Monetize Proprietary Platforms, IP, Intangible Assets, etc. Increase Venture value through Collateralization Fund Obligation.

This document contains private and confidential information and is not to be distributed to the general public.

LIFE Powershares Co Highlights

LIFE Reverse Equity Fund IV Partnership. Over 30+ Companies: Strategic Alliances, Ownership & Partnerships.

Collective Vested Interest: Mutual Benefit.

Higher Probability of Success. Exponential Revenue Growth Model.

Faster Exits & Capitalization (All Stages).

Higher Collective & Individual Valuation. Predefined Capital Infusion & Exits. Full Post-Investment Security for Shareholders.

This document contains private and confidential information and is not to be distributed to the general public.

LIFE Reverse Equity Fund IV

Thawer & Co., VII LLP.

Healthcare Fund (NA Ventures)

Enhancing Human Lives through Conceptualization, Innovation & Implementation.
For Full Presentation regarding LIFE Reverse Equity Fund IV, please contact Rahim Thawer at rahim.thawer@thawerco.com. LIFE Reverse Equity Fund IV Partnership is open by Invitation Only upon successful analysis.

This document contains private and confidential information and is not to be distributed to the general public.